Assyro AI
FDA 483 Database

FDA Form 483s Issued in May 2023

Every published Form FDA 483 issued in May 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

9

Published 483s in May 2023

9

Distinct firms

Form 483s issued in May 2023

Sanofi S.p.A.FDA
FEI
3002807108
Issued
May 22, 2023
Establishment
Drug Manufacturer
Location
Italy
Laboratorios Farmaceuticos Rovi S. A.FDA
FEI
3010705046
Issued
May 19, 2023
Establishment
Sterile Drug Manufacturer
Location
Spain
Wuxi Biologics Co., Ltd.FDA
FEI
3010606982
Issued
May 9, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
China
Patheon Italia S.p.A.FDA
FEI
3003065803
Issued
May 26, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Italy
Apicore Pharmaceuticals Private Ltd.FDA
FEI
3006767695
Issued
May 5, 2023
Establishment
Human Drug Manufacturer
Location
India
Medi-Fare DrugFDA
FEI
3009925820
Issued
May 26, 2023
Establishment
Outsourcing Facility
Location
South Carolina, United States
SCA PharmaceuticalsFDA
FEI
3010683157
Issued
May 17, 2023
Establishment
Outsourcing Facility
Location
Arkansas, United States
Catalent Indiana, LLCFDA
FEI
3005949964
Issued
May 12, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
United States
Intas Pharmaceuticals LimitedFDA
FEI
3003157498
Issued
May 12, 2023
Establishment
Human Drug Manufacturer
Location
India

Other months in 2023

Back to the FDA 483 Database